Protagonist Therapeutics Eulerpool News

Protagonist Therapeutics Aktie News

Protagonist Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Protagonist Therapeutics News stellen wir hier zusammen.

• 13. November ·

  Yahoo
  Protagonist Therapeutics (PTGX) Upgraded to Buy: Here's What You Should Know
• 7. November ·

  Yahoo
  Protagonist Therapeutics (PTGX) Reports Q3 Loss, Tops Revenue Estimates
• 7. November ·

  Yahoo
  Protagonist Therapeutics: Q3 Earnings Snapshot
• 7. November ·

  Yahoo
  Protagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update
• 5. November ·

  Yahoo
  Protagonist Therapeutics Announces Poster Presentation on Final REVIVE Phase 2 Study Data with Rusfertide at the 66th Annual ASH Meeting
• 29. Oktober ·

  Accesswire
  Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million
• 18. Oktober ·

  Yahoo
  Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases
• 16. Oktober ·

  Yahoo
  State Street Corp's Strategic Acquisition in Protagonist Therapeutics Inc
• 16. Oktober ·

  SeekingAlpha
  The Prognosis For Protagonist Therapeutics: Solid Prospects, But Stock Is Pricey
• 14. Oktober ·

  TipRanks
  TD Cowen Keeps Their Buy Rating on Protagonist Therapeutics (PTGX)